KiYChungMD

Oncology • Boiling Springs, SC

Breast Cancer, Gastrointestinal Cancer, Hematologic Oncology

Associate professor of medicine, MD

Join to view full profile

Dr. Chung is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Chung's full profile

Already have an account?

Office
2400 Boiling Springs Rd
Boiling Springs, SC 29316
Phone+1 864-599-0731

Fax+1 864-672-7852
Is this information wrong?

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1999 - 2003
Johns Hopkins UniversityResidency, Internal Medicine, 1995 - 1999
University of North Carolina at Chapel Hill School of MedicineClass of 1995

Certifications & Licensure

SC State Medical License 2011 - 2023
NY State Medical License 1999 - 2013
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013

Clinical Trials

Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer Start of enrollment: 2011 Apr 01
Terminated
Phase 3
Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300) Start of enrollment: 2015 Dec 28
Completed
Phase 3
Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL) Start of enrollment: 2016 Mar 01
Completed
Phase 1

Publications & Presentations

PubMed

1 citations
Phase 1 study to evaluate the effects of rifampin on pharmacokinetics of pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors.
Xiaofei Zhou, Ulka Vaishampayan, Devalingam Mahalingam, R Donald Harvey, Ki Young Chung, Farhad Sedarati, Cassie Dong, Douglas V Faller, Karthik Venkatakrishnan, Neera...> ;Investigational New Drugs. 2022 Oct 1
8 citations
A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer
Ruth Plummer, Emma Dean, Hendrik-Tobias Arkenau, Charles H. Redfern, Alexander I. Spira, Jason M. Melear, Ki Y. Chung, Jordi Ferrer-Playan, Thomas Goddemeier, Giuseppe...> ;Lung Cancer. 2021 Dec 1
24 citations
Phase 1 Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-Type TP53.
Mansoor N. Saleh, Manish R. Patel, Todd M. Bauer, Sanjay Goel, Gerald Steven Falchook, Geoffrey I. Shapiro, Ki Y. Chung, Jeffrey R. Infante, Robert M. Conry, Guilherme...> ;Clinical Cancer Research. 2021 Oct 1
96 citations
Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial.
Salvatore Siena, Maria Di Bartolomeo, Kanwal Pratap Singh Raghav, Toshiki Masuishi, Fotios Loupakis, Hisato Kawakami, Kensei Yamaguchi, Tomohiro Nishina, Marwan Fakih,...> ;The Lancet. Oncology. 2021 May 4
7 citations
A Phase II Study of Durvalumab in Combination with Tremelimumab in Patients with Rare Cancers.
William Jeffery Edenfield, Ki Y. Chung, Mark Allen O'Rourke, Elizabeth H. Cull, Julie C. Martin, Heather Bowers, Wesley M. Smith, William Larry Gluck> ;The Oncologist. 2021 Sep 1
14 citations
Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumors
Jason J. Luke, Fabrice Barlesi, Ki Y. Chung, Anthony W. Tolcher, Karen Kelly, Antoine Hollebecque, Christophe Le Tourneau, Vivek Subbiah, Frank Tsai, Steven Kao, Phili...> ;Journal for Immunotherapy of Cancer. 2021 Feb 1
20 citations
Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study.
Aaron D Goldberg, Ehab Atallah, David A. Rizzieri, Roland B. Walter, Ki Y. Chung, Alexander I. Spira, Wendy Stock, Martin S. Tallman, Hans G Cruz, Joseph Boni, Karin H...> ;Leukemia Research. 2020 Aug 1
129 citations
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper.
Arvind Dasari, Van K. Morris, Carmen J. Allegra, Chloe E. Atreya, Al B. Benson, Patrick McKay Boland, Ki Y. Chung, Mehmet Sitki Copur, Ryan B. Corcoran, Dustin A. Demi...> ;Nature Reviews. Clinical Oncology. 2020 Jul 6
15 citations
Early postoperative intraperitoneal chemotherapy following cytoreductive surgery for appendiceal mucinous neoplasms with isolated peritoneal metastasis.
Patrick L. Wagner, Douglas W. Jones, Anna Aronova, Jinru Shia, Martin R. Weiser, Larissa K. Temple, Ki Y. Chung, Eileen M. O'Reilly, David P. Kelsen, Philip B. Paty, G...> ;Diseases of The Colon & Rectum. 2012 Apr 1
34 citations
A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma
Ana De Jesus-Acosta, George R. Oliver, Amanda L. Blackford, Katharine Kinsman, Edna I. Flores, Lalan S. Wilfong, Lei Zheng, Ross C. Donehower, David Cosgrove, Daniel A...> ;Cancer Chemotherapy and Pharmacology. 2012 Feb 1
6 citations
Phase I Study of Two Schedules of Oral S-1 in Combination with Fixed Doses of Oxaliplatin and Bevacizumab in Patients with Advanced Solid Tumors
Ki Y. Chung, Kaku Saito, Christopher Zergebel, Ellen Hollywood, Michal Segal, Leonard B. Saltz> ;Oncology. 2011 Jan 1
203 citations
Phase II Study of the Anti-Cytotoxic T-Lymphocyte–Associated Antigen 4 Monoclonal Antibody, Tremelimumab, in Patients With Refractory Metastatic Colorectal Cancer
Ki Y. Chung, Ira Gore, Lawrence Fong, Alan P. Venook, Stephen B. Beck, Prudence Dorazio, Peggy J. Criscitiello, Diane Healey, Bo Huang, Jesus Gomez-Navarro, Leonard B....> ;Journal of Clinical Oncology. 2010 Jul 20
30 citations
G3139 (Genasense) in patients with advanced merkel cell carcinoma.
Manisha H. Shah, Kimberly A. Varker, Minden Collamore, James A. Zwiebel, Daniel G. Coit, David P. Kelsen, Ki Y. Chung> ;American Journal of Clinical Oncology. 2009 Apr 1
47 citations
A phase 1 dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumors
Archie N. Tse, David S. Klimstra, Mithat Gonen, Manish A. Shah, Tahir Sheikh, Rachel P. Sikorski, Richard D. Carvajal, Janet Mui, Caroll Tipian, Eileen M. O'Reilly, Ki...> ;Clinical Cancer Research. 2008 Oct 15
33 citations
Pneumatosis intestinalis: a variant of bevacizumab related perforation possibly associated with chemotherapy related GI toxicity.
Timothy R. Asmis, Ki Y. Chung, Jerrold B. Teitcher, David P. Kelsen, Manish A. Shah> ;Investigational New Drugs. 2008 Feb 1
44 citations
Bevacizumab 5 mg/kg Can Be Infused Safely Over 10 Minutes
Diane Lauren Reidy, Ki Y. Chung, John P. Timoney, Vivian Park, Ellen Hollywood, Nancy Sklarin, Raymond J. Muller, Leonard B. Saltz> ;Journal of Clinical Oncology. 2007 Jul 1
51 citations
NUP98 dysregulation in myeloid leukemogenesis.
Malcom A.S. Moore, Ki Y. Chung, Magdalena Plasilova, Jan Jacob Schuringa, J.-H. Shieh, Pengbo Zhou, Giovanni Morrone> ;Annals of the New York Academy of Sciences. 2007 Jun 1
66 citations
Adjuvant therapy of colon cancer: current status and future directions.
Ki Y. Chung, Leonard B. Saltz> ;Cancer Journal. 2007 May 1
45 citations
Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells
Malcolm A.S. Moore, David C. Dorn, Jan Jacob Schuringa, Ki Y. Chung, Giovanni Morrone> ;Experimental Hematology. 2007 Apr 1
52 citations
Enforced expression of NUP98-HOXA9 in human CD34(+) cells enhances stem cell proliferation
Ki Y. Chung, Giovanni Morrone, Jan Jacob Schuringa, Magdalena Plasilova, Jae-Hung Shieh, Yue Zhang, Pengbo Zhou, Malcolm A.S. Moore> ;Cancer Research. 2006 Dec 15
35 citations
Antibody-Based Therapies for Colorectal Cancer
Ki Y. Chung, Leonard B. Saltz> ;Oncologist. 2005 Oct 1
14 citations
Regional and systemic chemotherapy for primary hepatobiliary cancers and for colorectal cancer metastatic to the liver.
Ki Y. Chung, Nancy E. Kemeny> ;Seminars in Radiation Oncology. 2005 Oct 1
113 citations
Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization study.
Jinru Shia, David S. Klimstra, Allan R. Li, Jing Qin, Leonard B. Saltz, Julie Teruya-Feldstein, Muzaffar Akram, Ki Y. Chung, Davis Yao, Philip B. Paty, William L. Gera...> ;Modern Pathology. 2005 Oct 1
168 citations
Cetuximab Therapy and Symptomatic Hypomagnesemia
Deborah Schrag, Ki Y. Chung, Carlos D. Flombaum, Leonard B. Saltz> ;Journal of the National Cancer Institute. 2005 Aug 17
863 citations
Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry
Ki Y. Chung, Jinru Shia, Nancy E. Kemeny, Manish A. Shah, Gary K. Schwartz, Archie Tse, Audrey Hamilton, Dorothy Pan, Deborah Schrag, Lawrence H. Schwartz, David S. Kl...> ;Journal of Clinical Oncology. 2005 Mar 20
Join now to see all

Hospital Affiliations

Prisma Health Greenville Memorial HospitalGreenville, South Carolina
Spartanburg Medical Center - Mary BlackSpartanburg, South Carolina
Spartanburg Medical Center - Church Street CampusSpartanburg, South Carolina
Prisma Health Patewood HospitalGreenville, South Carolina